Below is a list of the 20 most expensive prescription drugs in the U.S., based on the official price their manufacture assigned to them, as compiled by prescription discount company GoodRx. This list excludes medications that must be administered by a healthcare practitioner.
- Zokinvy (Eiger BioPharmaceuticals): $86,040
- Myalept (Aegerion Pharmaceuticals): $74,159
- Mavenclad (EMD Serono): $60,371
- Ravicti (Horizon Therapeutics): $57,998
- Actimmune (Horizon Therapeutics): $55,310
- Oxervate (Dompé): $48,498
- Takhzyro (Takeda): $46,828
- Juxtapid (Aegerion Pharmaceuticals): $46,502
- Cinryze (Takeda): $45,465
- Chenodal (Travere Therapeutics): $42,570
- Gattex (Takeda): $41,664
- H.P. Acthar (Mallinckrodt Pharmaceuticals): $39,864
- Orladeyo (BioCryst Pharmaceuticals): $37,308
- Tegsedi (Akcea Therapeutics): $35,638
- Ayvakit (Blueprint Medicines): $33,568
- Vitrakvi (Bayer Pharmaceuticals): $32,800
- Qinlock (Decipera Pharmaceuticals): $32,000
- Korlym (Corcept Therapeutics): $31,440
- Cerdelga (Genzyme): $28,599
- Idhifa (Celgene): $28,246
More articles on pharmacy:
J&J submits FDA application for COVID-19 vaccine
Pentagon to deploy troops to help with COVID-19 vaccine administration
AstraZeneca’s vaccine may not effectively protect against South Africa variant, small trial shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
